NCT06551857
- Conditions
- Cancer, Chemically-Induced Disorders, Cognition Disorders, +21 more
- Locations
-
- Turku University Hospital Turku, Southwest Finland, Finland
Clinical trial condition
Hearing Loss Ototoxic
Explore clinical trials studying Hearing Loss Ototoxic. Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
Hearing Loss Ototoxic trial results
Completed
SENS-401 to Prevent the Ototoxicity Induced by Cisplatin in Adult Subjects With a Neoplastic Disease
NCT05628233
- Conditions
- Hearing Loss Ototoxic
- Locations
-
- Hôpital Henri Mondor Créteil, France
NCT03400709
- Conditions
- Chemically-Induced Disorders, Cisplatin Adverse Reaction, Drug-Related Side Effects and Adverse Reactions, +8 more
- Locations
-
- Daniel Munoz Santiago, Santiago Metropolitan, Chile